RECORDATI: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
RECORDATI
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€1.7m
2024 · €1.7m+€44,292
Equity
€2.0m
2024 · €250,163+€1.7m
Cash
€4.5m
2024 · €1.4m+€3.1m
Balance sheet total
€20.8m
2024 · €15.7m+€5.1m
Largest movements
Assets
- Cash +€3.1m
up €3.1m (+217.0%), from €1.4m to €4.5m
mainly Trade debts (+€8.4m) and Net result for the year (+€1.7m)
- Receivables within one year +€1.6m
up €1.6m (+14.4%), from €10.9m to €12.5m
of which Trade receivables: +€3.4m
- Stocks and contracts +€355,552
up €355,552 (+11.2%), from €3.2m to €3.5m
Equity and liabilities
- Trade debts +€8.4m
up €8.4m (+104.9%), from €8.0m to €16.4m
- Other debts -€5.6m
down €5.6m (-100.0%), from €5.6m to €0
- Profit (loss) carried forward +€1.7m
up €1.7m (+744.5%), from €229,703 to €1.9m
- Accrued charges and deferred income +€444,342
up €444,342 (+150.5%), from €295,234 to €739,576
Income statement
- Turnover +€7.7m
up €7.7m (+22.3%), from €34.8m to €42.5m
- Goods and materials +€5.3m
up €5.3m (+27.7%), from €19.1m to €24.4m
of which Purchases: +€5.2m
- Services and other goods +€1.1m
up €1.1m (+13.6%), from €7.9m to €8.9m
- Staff costs +€573,377
up €573,377 (+9.1%), from €6.3m to €6.9m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€1.7m
Turnover
+€7.7m
Other operating income
-€307,661
Goods and materials
-€5.3m
Services and other goods
-€1.1m
Staff costs
-€573,377
Depreciation
-€11,373
Write-downs
+€177,448
Other operating charges
-€316,665
Financial income
-€388,853
Financial charges
-€7,857
Taxes
+€95,768
Result 2025
€1.7m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€3.2m
Investment
-€175,075
Financing
€0
Cash 2024
€1.4m
From operations (derived)
+€3.2m
Net result for the year
+€1.7m
Depreciation
+€67,702
Stocks and contracts
-€355,552
Receivables within one year
-€1.6m
Deferred charges and accrued income
+€8,469
Trade debts
+€8.4m
Tax, wage and social debts
+€110,992
Other debts
-€5.6m
Accrued charges and deferred income
+€444,342
Investment (derived)
-€175,075
Investment in fixed assets (net)
-€175,075
Cash 2025
€4.5m
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €15,711,079 | €20,802,351 | +€5.1m | +32.4% |
| Fixed assets | 21/28 | €202,939 | €310,312 | +€107,373 | +52.9% |
| Tangible fixed assets | 22/27 | €202,939 | €310,312 | +€107,373 | +52.9% |
| Plant, machinery and equipment | 23 | €49,478 | €87,703 | +€38,225 | +77.3% |
| Furniture and vehicles | 24 | €30,611 | €68,079 | +€37,468 | +122.4% |
| Other tangible fixed assets | 26 | €122,850 | €154,530 | +€31,680 | +25.8% |
| Current assets | 29/58 | €15,508,140 | €20,492,039 | +€5.0m | +32.1% |
| Stocks and contracts in progress | 3 | €3,168,289 | €3,523,841 | +€355,552 | +11.2% |
| Stocks | 30/36 | €3,168,289 | €3,523,841 | +€355,552 | +11.2% |
| Goods purchased for resale | 34 | €3,168,289 | €3,523,841 | +€355,552 | +11.2% |
| Amounts receivable within one year | 40/41 | €10,919,119 | €12,493,041 | +€1.6m | +14.4% |
| Trade receivables | 40 | €7,973,903 | €11,393,806 | +€3.4m | +42.9% |
| Other amounts receivable | 41 | €2,945,217 | €1,099,235 | -€1.8m | -62.7% |
| Cash at bank and in hand | 54/58 | €1,411,732 | €4,474,626 | +€3.1m | +217.0% |
| Deferred charges and accrued income | 490/1 | €9,000 | €531 | -€8,469 | -94.1% |
| Total equity and liabilities | 10/49 | €15,711,079 | €20,802,351 | +€5.1m | +32.4% |
| Equity | 10/15 | €250,163 | €1,960,213 | +€1.7m | +683.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €229,703 | €1,939,753 | +€1.7m | +744.5% |
| Amounts payable | 17/49 | €15,460,916 | €18,842,138 | +€3.4m | +21.9% |
| Amounts payable within one year | 42/48 | €15,165,682 | €18,102,562 | +€2.9m | +19.4% |
| Trade debts | 44 | €8,013,444 | €16,421,850 | +€8.4m | +104.9% |
| Suppliers | 440/4 | €8,013,444 | €16,421,850 | +€8.4m | +104.9% |
| Taxes, remuneration and social security | 45 | €1,569,720 | €1,680,711 | +€110,992 | +7.1% |
| Taxes | 450/3 | €29,927 | €26,418 | -€3,510 | -11.7% |
| Remuneration and social security | 454/9 | €1,539,792 | €1,654,294 | +€114,501 | +7.4% |
| Other amounts payable | 47/48 | €5,582,518 | €0 | -€5.6m | -100.0% |
| Accrued charges and deferred income | 492/3 | €295,234 | €739,576 | +€444,342 | +150.5% |
| Operating income | 70/76A | €35,473,314 | €42,907,841 | +€7.4m | +21.0% |
| Turnover | 70 | €34,772,811 | €42,514,999 | +€7.7m | +22.3% |
| Other operating income | 74 | €700,502 | €392,841 | -€307,661 | -43.9% |
| Operating charges | 60/66A | €33,551,150 | €40,640,443 | +€7.1m | +21.1% |
| Goods for resale, raw materials and consumables | 60 | €19,137,797 | €24,433,548 | +€5.3m | +27.7% |
| Purchases | 600/8 | €19,620,631 | €24,789,100 | +€5.2m | +26.3% |
| Change in stocks: decrease (increase) | 609 | -€482,834 | -€355,552 | +€127,282 | +26.4% |
| Services and other goods | 61 | €7,852,837 | €8,922,413 | +€1.1m | +13.6% |
| Remuneration, social security and pensions | 62 | €6,309,897 | €6,883,274 | +€573,377 | +9.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €56,328 | €67,702 | +€11,373 | +20.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €92,818 | -€84,630 | -€177,448 | |
| Other operating charges | 640/8 | €101,472 | €418,137 | +€316,665 | +312.1% |
| Non-recurring operating charges | 66A | €0 | - | = | |
| Operating profit (loss) | 9901 | €1,922,164 | €2,267,398 | +€345,234 | +18.0% |
| Financial income | 75/76B | €434,640 | €45,787 | -€388,853 | -89.5% |
| Recurring financial income | 75 | €434,640 | €45,787 | -€388,853 | -89.5% |
| Income from current assets | 751 | €423,644 | €45,787 | -€377,858 | -89.2% |
| Other financial income | 752/9 | €10,995 | €0 | -€10,995 | -100.0% |
| Financial charges | 65/66B | €41,797 | €49,654 | +€7,857 | +18.8% |
| Recurring financial charges | 65 | €41,797 | €49,654 | +€7,857 | +18.8% |
| Debt charges | 650 | €36,764 | €43,005 | +€6,241 | +17.0% |
| Other financial charges | 652/9 | €5,033 | €6,648 | +€1,616 | +32.1% |
| Profit (loss) for the period before taxes | 9903 | €2,315,007 | €2,263,531 | -€51,476 | -2.2% |
| Income taxes | 67/77 | €649,248 | €553,481 | -€95,768 | -14.8% |
| Taxes | 670/3 | €700,197 | €553,481 | -€146,716 | -21.0% |
| Tax adjustments and reversals of tax provisions | 77 | €50,949 | €0 | -€50,949 | -100.0% |
| Profit (loss) for the period | 9904 | €1,665,758 | €1,710,050 | +€44,292 | +2.7% |
| Profit (loss) for the period to be appropriated | 9905 | €1,665,758 | €1,710,050 | +€44,292 | +2.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.